Tofacitinib, sold under brand names such as Xeljanz, is a prescription medication used to treat various autoimmune and inflammatory conditions. It is a Janus kinase (JAK) inhibitor that works by decreasing the activity of the immune system to reduce inflammation and joint damage.
It is used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.
It is used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.
